Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""LEWY BODY"" wg kryterium: Temat


Tytuł :
Prevalence of the core clinical features and the other neuropsychiatric symptoms in dementia with Lewy bodies.
Autorzy :
Nagahama Y; Department of Psychiatry and Neurology, Kawasaki Memorial Hospital, Kawasaki, Japan.; Department of Geriatric Neurology, Shiga General Hospital, Moriyama, Japan.
Okina T; Department of Geriatric Neurology, Shiga General Hospital, Moriyama, Japan.
Suzuki N; Department of Geriatric Neurology, Shiga General Hospital, Moriyama, Japan.
Matsuda M; Department of Geriatric Neurology, Shiga General Hospital, Moriyama, Japan.; Department of Neurology, Izuminomori Clinic, Sendai, Japan.
Pokaż więcej
Źródło :
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society [Psychogeriatrics] 2021 May; Vol. 21 (3), pp. 443-445. Date of Electronic Publication: 2021 Mar 23.
Typ publikacji :
Journal Article
MeSH Terms :
Lewy Body Disease*/complications
Lewy Body Disease*/diagnosis
Lewy Body Disease*/epidemiology
Humans ; Lewy Bodies ; Prevalence
Czasopismo naukowe
Tytuł :
Benzodiazepines and antidepressants: Effects on cognitive and functional decline in Alzheimer's disease and Lewy body dementia.
Autorzy :
Borda MG; Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway.; Semillero de Neurociencias y Envejecimiento, Ageing Institute, Medical School, Pontificia Universidad Javeriana, Bogotá, Colombia.; Faculty of Health Sciences, University of Stavanger, Stavanger, Norway.
Jaramillo-Jimenez A; Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway.; Faculty of Health Sciences, University of Stavanger, Stavanger, Norway.; Grupo de Neurociencias de Antioquia, Medical School, Universidad de Antioquia, Medellin, Colombia.
Oesterhus R; Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway.; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
Santacruz JM; Semillero de Neurociencias y Envejecimiento, Ageing Institute, Medical School, Pontificia Universidad Javeriana, Bogotá, Colombia.; Cognition and Memory Center, Intellectus, Hospital Universitario San Ignacio, Bogotá, Colombia.; Psychiatry Department, Hospital Universitario San Ignacio, Bogotá, Colombia.
Tovar-Rios DA; Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway.; School of Statistics, Faculty of Engineering, Universidad Del Valle, Santiago de Cali, Colombia.; Department of Mathematics and Statistics, Faculty of Basic Sciences, Universidad Autónoma de Occidente, Santiago de Cali, Colombia.
Soennesyn H; Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway.
Cano-Gutierrez CA; Semillero de Neurociencias y Envejecimiento, Ageing Institute, Medical School, Pontificia Universidad Javeriana, Bogotá, Colombia.; Geriatric Unit, Hospital Universitario San Ignacio, Bogotá, Colombia.
Vik-Mo AO; Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway.; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
Aarsland D; Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway.; Department of Old Age Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.
Pokaż więcej
Źródło :
International journal of geriatric psychiatry [Int J Geriatr Psychiatry] 2021 Jun; Vol. 36 (6), pp. 917-925. Date of Electronic Publication: 2021 Jan 16.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Alzheimer Disease*/drug therapy
Lewy Body Disease*/drug therapy
Aged ; Antidepressive Agents/therapeutic use ; Benzodiazepines/adverse effects ; Cognition ; Cohort Studies ; Humans ; Norway/epidemiology
Czasopismo naukowe
Tytuł :
Genetic Architecture and Molecular, Imaging and Prodromic Markers in Dementia with Lewy Bodies: State of the Art, Opportunities and Challenges.
Autorzy :
Combi R; School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.
Salsone M; Institute of Molecular Bioimaging and Physiology, National Research Council, 20054 Segrate (MI), Italy.; Department of Clinical Neurosciences, Neurology-Sleep Disorder Center, IRCCS San Raffaele Scientific Institute, 20127 Milan, Italy.
Villa C; School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.
Ferini-Strambi L; Department of Clinical Neurosciences, Neurology-Sleep Disorder Center, IRCCS San Raffaele Scientific Institute, 20127 Milan, Italy.; Department of Clinical Neurosciences, 'Vita-Salute' San Raffaele University, 20127 Milan, Italy.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Apr 12; Vol. 22 (8). Date of Electronic Publication: 2021 Apr 12.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Biomarkers/*blood
Dementia/*genetics
Lewy Body Disease/*genetics
Synucleinopathies/*genetics
Biomarkers/cerebrospinal fluid ; Dementia/blood ; Dementia/diagnostic imaging ; Dementia/pathology ; Diagnosis, Differential ; Diagnostic Imaging/methods ; Humans ; Lewy Bodies/genetics ; Lewy Bodies/pathology ; Lewy Body Disease/blood ; Lewy Body Disease/diagnostic imaging ; Lewy Body Disease/pathology ; Synucleinopathies/blood ; Synucleinopathies/diagnostic imaging ; Synucleinopathies/pathology
Czasopismo naukowe
Tytuł :
Microglia is associated with p-Tau aggregates in the olfactory bulb of patients with neurodegenerative diseases.
Autorzy :
Carmona-Abellan M; Health Research Institute Biocruces, Barakaldo, Vizcaya, Spain. .
Martinez-Valbuena I; Centro de Investigación Médica Aplicada, CIMA, Pamplona, Navarra, Spain.; HRI Navarra, IdisNA, Pamplona, Navarra, Spain.
Marcilla I; Centro de Investigación Médica Aplicada, CIMA, Pamplona, Navarra, Spain.; HRI Navarra, IdisNA, Pamplona, Navarra, Spain.
DiCaudo C; Centro Neuromedico, Granada, Spain.
Gil I; HRI Navarra, IdisNA, Pamplona, Navarra, Spain.; Navarrabiomed, Pamplona, Navarra, Spain.
Nuñez J; Clinica Universidad de Navarra, Pamplona, Navarra, Spain.
Luquin MR; HRI Navarra, IdisNA, Pamplona, Navarra, Spain.; Clinica Universidad de Navarra, Pamplona, Navarra, Spain.
Pokaż więcej
Źródło :
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2021 Apr; Vol. 42 (4), pp. 1473-1482. Date of Electronic Publication: 2020 Aug 20.
Typ publikacji :
Journal Article
MeSH Terms :
Alzheimer Disease*
Lewy Body Disease*
Microglia*/metabolism
Neurodegenerative Diseases*
Olfactory Bulb*
Aged ; Humans ; alpha-Synuclein/metabolism
Czasopismo naukowe
Tytuł :
The revised Addenbrooke's Cognitive Examination can facilitate differentiation of dementia with Lewy bodies from Alzheimer's disease.
Autorzy :
Prats-Sedano MA; Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Savulich G; Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Surendranathan A; Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Donaghy PC; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Thomas AJ; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Rowe JB; Department of Clinical Neurosciences, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Su L; Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
O'Brien JT; Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Pokaż więcej
Źródło :
International journal of geriatric psychiatry [Int J Geriatr Psychiatry] 2021 Jun; Vol. 36 (6), pp. 831-838. Date of Electronic Publication: 2020 Dec 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Alzheimer Disease*/diagnosis
Lewy Body Disease*/diagnosis
Cognition ; Diagnosis, Differential ; Humans ; Memory ; Neuropsychological Tests
Czasopismo naukowe
Tytuł :
Association of cerebral microbleeds with cerebrospinal fluid Alzheimer-biomarkers and clinical symptoms in early dementia with Lewy bodies.
Autorzy :
Mendes A; Division of Geriatrics and Geneva Memory Center, Geneva University Hospitals, Geneva, Switzerland.
Noblet V; IMIS Team and IRIS Plateform, ICube Laboratory, UMR 7357, French National Centre for Scientific Research (CNRS), Strasbourg, France.; Fédération de Médecine Translationnelle de Strasbourg (FMTS), University of Strasbourg, Strasbourg, France.
Mondino M; IMIS Team and IRIS Plateform, ICube Laboratory, UMR 7357, French National Centre for Scientific Research (CNRS), Strasbourg, France.; Fédération de Médecine Translationnelle de Strasbourg (FMTS), University of Strasbourg, Strasbourg, France.
Loureiro de Sousa P; IMIS Team and IRIS Plateform, ICube Laboratory, UMR 7357, French National Centre for Scientific Research (CNRS), Strasbourg, France.; Fédération de Médecine Translationnelle de Strasbourg (FMTS), University of Strasbourg, Strasbourg, France.
Manji S; IMIS Team and IRIS Plateform, ICube Laboratory, UMR 7357, French National Centre for Scientific Research (CNRS), Strasbourg, France.; Fédération de Médecine Translationnelle de Strasbourg (FMTS), University of Strasbourg, Strasbourg, France.
Archenault A; IMIS Team and IRIS Plateform, ICube Laboratory, UMR 7357, French National Centre for Scientific Research (CNRS), Strasbourg, France.; Fédération de Médecine Translationnelle de Strasbourg (FMTS), University of Strasbourg, Strasbourg, France.
Casanovas M; IMIS Team and IRIS Plateform, ICube Laboratory, UMR 7357, French National Centre for Scientific Research (CNRS), Strasbourg, France.; Fédération de Médecine Translationnelle de Strasbourg (FMTS), University of Strasbourg, Strasbourg, France.
Bousiges O; Laboratoire de Biochimie et Biologie Moléculaire, University Hospital of Strasbourg, Strasbourg, France.; Laboratoire de Neurosciences Cognitives et Adaptatives (LNCA), UMR 7364, CNRS, Strasbourg, France.; Neuroradiology Service, University Hospital of Strasbourg, Strasbourg, France.
Philippi N; IMIS Team and IRIS Plateform, ICube Laboratory, UMR 7357, French National Centre for Scientific Research (CNRS), Strasbourg, France.; Fédération de Médecine Translationnelle de Strasbourg (FMTS), University of Strasbourg, Strasbourg, France.; Memory Resources and Research Centre (CM2R), Geriatrics Day Hospital and Neuropsychology Unit, Geriatrics Department and Neurology Service, University Hospital of Strasbourg, Strasbourg, France.
Baloglu S; IMIS Team and IRIS Plateform, ICube Laboratory, UMR 7357, French National Centre for Scientific Research (CNRS), Strasbourg, France.; Fédération de Médecine Translationnelle de Strasbourg (FMTS), University of Strasbourg, Strasbourg, France.; Laboratoire de Neurosciences Cognitives et Adaptatives (LNCA), UMR 7364, CNRS, Strasbourg, France.
Rauch L; Memory Resources and Research Centre (CM2R), Geriatrics Day Hospital and Neuropsychology Unit, Geriatrics Department and Neurology Service, University Hospital of Strasbourg, Strasbourg, France.
Cretin B; IMIS Team and IRIS Plateform, ICube Laboratory, UMR 7357, French National Centre for Scientific Research (CNRS), Strasbourg, France.; Fédération de Médecine Translationnelle de Strasbourg (FMTS), University of Strasbourg, Strasbourg, France.; Memory Resources and Research Centre (CM2R), Geriatrics Day Hospital and Neuropsychology Unit, Geriatrics Department and Neurology Service, University Hospital of Strasbourg, Strasbourg, France.
Demuynck C; Memory Resources and Research Centre (CM2R), Geriatrics Day Hospital and Neuropsychology Unit, Geriatrics Department and Neurology Service, University Hospital of Strasbourg, Strasbourg, France.
Martin-Hunyadi C; Memory Resources and Research Centre (CM2R), Geriatrics Day Hospital and Neuropsychology Unit, Geriatrics Department and Neurology Service, University Hospital of Strasbourg, Strasbourg, France.
Blanc F; IMIS Team and IRIS Plateform, ICube Laboratory, UMR 7357, French National Centre for Scientific Research (CNRS), Strasbourg, France.; Fédération de Médecine Translationnelle de Strasbourg (FMTS), University of Strasbourg, Strasbourg, France.; Memory Resources and Research Centre (CM2R), Geriatrics Day Hospital and Neuropsychology Unit, Geriatrics Department and Neurology Service, University Hospital of Strasbourg, Strasbourg, France.
Pokaż więcej
Źródło :
International journal of geriatric psychiatry [Int J Geriatr Psychiatry] 2021 Jun; Vol. 36 (6), pp. 851-857. Date of Electronic Publication: 2020 Dec 26.
Typ publikacji :
Journal Article
MeSH Terms :
Alzheimer Disease*
Lewy Body Disease*
Amyloid beta-Peptides ; Biomarkers ; Cerebral Hemorrhage ; Cross-Sectional Studies ; Humans ; Peptide Fragments ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Protocol for an observational cohort study identifying factors predicting accurately end of life in dementia with Lewy bodies and promoting quality end-of-life experiences: the PACE-DLB study.
Autorzy :
Armstrong MJ; Neurology, University of Florida College of Medicine, Gainesville, Florida, USA .
Paulson HL; Neurology, University of Michigan, Ann Arbor, Michigan, USA.
Maixner SM; Psychiatry, University of Michigan, Ann Arbor, Michigan, USA.
Fields JA; Psychiatry and Psychology, Mayo Clinic Rochester, Rochester, Minnesota, USA.
Lunde AM; Psychiatry and Psychology, Mayo Clinic Rochester, Rochester, Minnesota, USA.
Boeve BF; Neurology, Mayo Clinic Rochester, Rochester, Minnesota, USA.
Manning C; Neurology, University of Virginia, Charlottesville, Virginia, USA.
Galvin JE; Neurology, University of Miami Miller School of Medicine, Miami, Florida, USA.
Taylor AS; Lewy Body Dementia Association, Lilburn, Georgia, USA.
Li Z; Biostatistics, University of Florida College of Medicine, Gainesville, Florida, USA.
Pokaż więcej
Źródło :
BMJ open [BMJ Open] 2021 May 26; Vol. 11 (5), pp. e047554. Date of Electronic Publication: 2021 May 26.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Lewy Body Disease*
Cohort Studies ; Death ; Humans ; Longitudinal Studies ; Observational Studies as Topic ; Quality of Life
Czasopismo naukowe
Tytuł :
Early diagnosis of prodromal dementia with Lewy bodies using clinical history of probable REM sleep behaviour disorder and cardiac I-MIBG scintigraphy in memory clinics.
Autorzy :
Fujishiro H; Department of Psychiatry, Kawasaki Memorial Hospital, Kawasaki, Japan.; Department of Dementia diagnostic Centre, Yokohama Shintoshi Neurosurgery Hospital, Yokohama, Japan.
Ota K; Department of Dementia diagnostic Centre, Yokohama Shintoshi Neurosurgery Hospital, Yokohama, Japan.
Yamagata M; Department of Dementia diagnostic Centre, Yokohama Shintoshi Neurosurgery Hospital, Yokohama, Japan.
Ito T; Department of Neurology, Kawasaki Memorial Hospital, Kawasaki, Japan.
Hieda S; Department of Neurology, Kawasaki Memorial Hospital, Kawasaki, Japan.; Department of Neurology, Showa University, Tokyo, Japan.
Suga H; Department of Psychiatry, Kawasaki Memorial Hospital, Kawasaki, Japan.
Fukui T; Department of Neurology, Kawasaki Memorial Hospital, Kawasaki, Japan.
Nagahama Y; Department of Neurology, Kawasaki Memorial Hospital, Kawasaki, Japan.
Pokaż więcej
Źródło :
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society [Psychogeriatrics] 2021 May; Vol. 21 (3), pp. 288-295. Date of Electronic Publication: 2021 Feb 10.
Typ publikacji :
Journal Article
MeSH Terms :
Lewy Body Disease*/diagnostic imaging
REM Sleep Behavior Disorder*
3-Iodobenzylguanidine ; Early Diagnosis ; Female ; Humans ; Male ; Radionuclide Imaging
Czasopismo naukowe
Tytuł :
Added Value of QEEG for the Differential Diagnosis of Common Forms of Dementia.
Autorzy :
Livinț Popa L; Department of Neurosciences, 37576'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Cluj, Romania.; RoNeuro Institute for Neurological Research and Diagnostic, Cluj-Napoca, Cluj, Romania.
Dragoș HM; RoNeuro Institute for Neurological Research and Diagnostic, Cluj-Napoca, Cluj, Romania.
Strilciuc Ș; Department of Neurosciences, 37576'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Cluj, Romania.; RoNeuro Institute for Neurological Research and Diagnostic, Cluj-Napoca, Cluj, Romania.
Pantelemon C; Department of Neurosciences, 37576'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Cluj, Romania.; RoNeuro Institute for Neurological Research and Diagnostic, Cluj-Napoca, Cluj, Romania.
Mureșanu I; Department of Neurosciences, 37576'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Cluj, Romania.; RoNeuro Institute for Neurological Research and Diagnostic, Cluj-Napoca, Cluj, Romania.
Dina C; 112969Faculty of Medicine, 'Ovidius University,' Constanta, Romania.
Văcăraș V; Department of Neurosciences, 37576'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Cluj, Romania.; RoNeuro Institute for Neurological Research and Diagnostic, Cluj-Napoca, Cluj, Romania.
Mureșanu D; Department of Neurosciences, 37576'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Cluj, Romania.; RoNeuro Institute for Neurological Research and Diagnostic, Cluj-Napoca, Cluj, Romania.
Pokaż więcej
Źródło :
Clinical EEG and neuroscience [Clin EEG Neurosci] 2021 May; Vol. 52 (3), pp. 201-210. Date of Electronic Publication: 2020 Nov 08.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Alzheimer Disease*/diagnosis
Lewy Body Disease*/diagnosis
Parkinson Disease*/diagnosis
Diagnosis, Differential ; Electroencephalography ; Humans
Czasopismo naukowe
Tytuł :
Electroencephalogram in dementia with Lewy bodies: a systematic review.
Autorzy :
Chatzikonstantinou S; Third Department of Neurology, Aristotle University of Thessaloniki, 3 Arsaki Street, Pefka, 57010, Thessaloníki, Greece. .
McKenna J; Leeds Teaching Hospitals, Leeds, UK.
Karantali E; Third Department of Neurology, Aristotle University of Thessaloniki, 3 Arsaki Street, Pefka, 57010, Thessaloníki, Greece.
Petridis F; Third Department of Neurology, Aristotle University of Thessaloniki, 3 Arsaki Street, Pefka, 57010, Thessaloníki, Greece.
Kazis D; Third Department of Neurology, Aristotle University of Thessaloniki, 3 Arsaki Street, Pefka, 57010, Thessaloníki, Greece.
Mavroudis I; Leeds Teaching Hospitals, Leeds, UK.; Medical School, Cyprus University, Nicosia, Cyprus.
Pokaż więcej
Źródło :
Aging clinical and experimental research [Aging Clin Exp Res] 2021 May; Vol. 33 (5), pp. 1197-1208. Date of Electronic Publication: 2020 May 07.
Typ publikacji :
Journal Article; Review; Systematic Review
MeSH Terms :
Alzheimer Disease*
Lewy Body Disease*/diagnosis
Parkinson Disease*
REM Sleep Behavior Disorder*
Electroencephalography ; Humans
Czasopismo naukowe
Tytuł :
Alpha-synuclein Levels in Cerebrospinal Fluid in Patients With Lewy Bodies Dementia and Other Neurodegenerative Disorders.
Autorzy :
Kawada T; Department of Hygiene and Public Health Nippon Medical School, Tokyo, Japan.
Pokaż więcej
Źródło :
Alzheimer disease and associated disorders [Alzheimer Dis Assoc Disord] 2021 Apr-Jun 01; Vol. 35 (2), pp. 187.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Lewy Body Disease*
Neurodegenerative Diseases*
Diagnosis, Differential ; Humans ; Lewy Bodies ; alpha-Synuclein
Czasopismo naukowe
Tytuł :
Response to the Letter to the Editor by Tomoyuki Kawada: "Alpha-Synuclein Levels in Cerebrospinal Fluid in Patients With Lewy Bodies Dementia and Other Neurodegenerative Disorders".
Autorzy :
Mavroudis I; Department of Neurology Leeds Teaching Hospitals Leeds, UK.
Petridis F; Third Department of Neurology Aristotle University of Thessaloniki Thessaloniki, Greece.
Chatzikonstantinou S; Third Department of Neurology Aristotle University of Thessaloniki Thessaloniki, Greece.
Kazis D; Third Department of Neurology Aristotle University of Thessaloniki Thessaloniki, Greece.
Pokaż więcej
Źródło :
Alzheimer disease and associated disorders [Alzheimer Dis Assoc Disord] 2021 Apr-Jun 01; Vol. 35 (2), pp. 187-188.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Lewy Body Disease*
Neurodegenerative Diseases*
Diagnosis, Differential ; Humans ; Lewy Bodies ; alpha-Synuclein
Czasopismo naukowe
Tytuł :
A comparison of the prevalence of Fear of Falling between older patients with Lewy body dementia, Alzheimer's disease, and without dementia.
Autorzy :
Soysal P; Department of Geriatric Medicine, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey. Electronic address: .
Tan SG; Department of Geriatric Medicine, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
Smith L; The Cambridge Centre for Sport and Exercise Science, Anglia Ruskin University, Cambridge, UK.
Pokaż więcej
Źródło :
Experimental gerontology [Exp Gerontol] 2021 Apr; Vol. 146, pp. 111248. Date of Electronic Publication: 2021 Jan 21.
Typ publikacji :
Journal Article
MeSH Terms :
Alzheimer Disease*/epidemiology
Lewy Body Disease*/epidemiology
Accidental Falls ; Aged ; Fear ; Humans ; Prevalence
Czasopismo naukowe
Tytuł :
Immunohistochemical Detection of Synuclein Pathology in Skin in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinsonism.
Autorzy :
Al-Qassabi A; Department of Neurology, McGill University-Montreal General Hospital, Montreal, Quebec, Canada.; Sultan Qaboos University Hospital, Muscat.
Tsao TS; Roche Tissue Diagnostics, Tucson, Arizona, USA.
Racolta A; Roche Tissue Diagnostics, Tucson, Arizona, USA.
Kremer T; Roche Pharmaceutical Research and Early Development, Roche Innovation Centre Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Cañamero M; Roche Pharmaceutical Research and Early Development, Penzberg, Germany.
Belousov A; Roche Pharmaceutical Research and Early Development, Roche Innovation Centre Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Santana MA; Roche Tissue Diagnostics, Tucson, Arizona, USA.
Beck RC; Roche Tissue Diagnostics, Tucson, Arizona, USA.
Zhang H; Roche Tissue Diagnostics, Tucson, Arizona, USA.
Meridew J; Roche Tissue Diagnostics, Tucson, Arizona, USA.
Pugh J; Roche Tissue Diagnostics, Tucson, Arizona, USA.
Lian F; Roche Tissue Diagnostics, Tucson, Arizona, USA.
Robida MD; Roche Tissue Diagnostics, Tucson, Arizona, USA.
Ritter M; Roche Centralised and Point of Care Solutions, Penzberg, Germany.
Czech C; Roche Pharmaceutical Research and Early Development, Roche Innovation Centre Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Beach TG; Banner Sun Health Research Institute, Sun City, Arizona, USA.
Pestic-Dragovich L; Roche Tissue Diagnostics, Tucson, Arizona, USA.
Taylor KI; Roche Pharmaceutical Research and Early Development, Roche Innovation Centre Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.; Faculty of Psychology, University of Basel, Basel, Switzerland.
Zago W; Prothena Biosciences Inc., South San Francisco, California, USA.
Tang L; Roche Tissue Diagnostics, Tucson, Arizona, USA.
Dziadek S; Roche Pharmaceutical Research and Early Development, Roche Innovation Centre Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Postuma RB; Department of Neurology, McGill University-Montreal General Hospital, Montreal, Quebec, Canada.; Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.; CARSM, CIUSSS-NÎM-Hôpital du Sacré-Cœur de Montréal, Montréal, Quebec, Canada.
Pokaż więcej
Źródło :
Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2021 Apr; Vol. 36 (4), pp. 895-904. Date of Electronic Publication: 2020 Nov 24.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Lewy Body Disease*
Parkinson Disease*
REM Sleep Behavior Disorder*
Humans ; Skin ; alpha-Synuclein
Czasopismo naukowe
Tytuł :
Clinical characteristics of Lewy body dementia in Chinese memory clinics.
Autorzy :
Gan J; Department of neurology, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Beijing, China.
Liu S; Department of Neurology, Tianjin Huanhu Hospital, Tianjin Key Laboratory of Cerebrovascular and of Neurodegenerative Diseases, Tianjin Dementia Institute, Tianjin, China.
Wang X; Department of Neurology, Tianjin Huanhu Hospital, Tianjin Key Laboratory of Cerebrovascular and of Neurodegenerative Diseases, Tianjin Dementia Institute, Tianjin, China.
Shi Z; Department of Neurology, Tianjin Huanhu Hospital, Tianjin Key Laboratory of Cerebrovascular and of Neurodegenerative Diseases, Tianjin Dementia Institute, Tianjin, China.
Shen L; Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.
Li X; Department of neurology, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Beijing, China.
Guo Q; Department of Gerontology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
Yuan J; Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.
Zhang N; Department of Neurology, Tianjin Medical University General Hospital, Tianjin, China.
You Y; Department of Neurology, Second Affiliated Hospital of Hainan Medical University, Haikou, China.
Lv Y; Department of Geriatrics, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Zheng D; Department of Neurology, Shengjing Hospital Affiliated to China Medical University, Shenyang, China.
Ji Y; Department of neurology, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Beijing, China. .; Department of Neurology, Tianjin Huanhu Hospital, Tianjin Key Laboratory of Cerebrovascular and of Neurodegenerative Diseases, Tianjin Dementia Institute, Tianjin, China. .
Pokaż więcej
Corporate Authors :
China Lewy Body Disease Collaborative Alliance
Źródło :
BMC neurology [BMC Neurol] 2021 Mar 31; Vol. 21 (1), pp. 144. Date of Electronic Publication: 2021 Mar 31.
Typ publikacji :
Journal Article
MeSH Terms :
Lewy Body Disease/*diagnosis
Lewy Body Disease/*epidemiology
Aged ; Aged, 80 and over ; China/epidemiology ; Female ; Humans ; Lewy Body Disease/pathology ; Male ; Middle Aged ; Prevalence
Czasopismo naukowe
Tytuł :
Lewy Body Disease is a Contributor to Logopenic Progressive Aphasia Phenotype.
Autorzy :
Buciuc M; Department of Neurology, Mayo Clinic, Rochester, MN.
Whitwell JL; Department of Radiology, Mayo Clinic, Rochester, MN.
Kasanuki K; Department of Neuroscience, Mayo Clinic, Jacksonville, FL.; Department of Neuropsychiatry, St. Marianna University School of Medicine, Kawasaki, Japan.
Graff-Radford J; Department of Neurology, Mayo Clinic, Rochester, MN.
Machulda MM; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN.
Duffy JR; Department of Neurology, Mayo Clinic, Rochester, MN.
Strand EA; Department of Neurology, Mayo Clinic, Rochester, MN.
Lowe VJ; Department of Radiology, Mayo Clinic, Rochester, MN.
Graff-Radford NR; Department of Neurology, Mayo Clinic, Jacksonville, FL.
Rush BK; Department of Psychiatry and Psychology, Mayo Clinic, Jacksonville, FL.
Franczak MB; Department of Neurology, Medical College of Wisconsin, Milwaukee, WI.
Flanagan ME; Department of Pathology, Cognitive Neurology and Alzheimer's Disease Center, Northwestern University Feinberg School of Medicine, Chicago, IL.
Baker MC; Department of Neuroscience, Mayo Clinic, Jacksonville, FL.
Rademakers R; Department of Neuroscience, Mayo Clinic, Jacksonville, FL.
Ross OA; Department of Neuroscience, Mayo Clinic, Jacksonville, FL.
Ghetti BF; Department of Pathology & Laboratory Medicine, Indiana University, Indianapolis, IN.
Parisi JE; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Raghunathan A; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Reichard RR; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Bigio EH; Department of Pathology, Cognitive Neurology and Alzheimer's Disease Center, Northwestern University Feinberg School of Medicine, Chicago, IL.
Dickson DW; Department of Neuroscience, Mayo Clinic, Jacksonville, FL.
Josephs KA; Department of Neurology, Mayo Clinic, Rochester, MN.
Pokaż więcej
Źródło :
Annals of neurology [Ann Neurol] 2021 Mar; Vol. 89 (3), pp. 520-533. Date of Electronic Publication: 2020 Dec 17.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Alzheimer Disease/*diagnostic imaging
Aphasia, Primary Progressive/*diagnostic imaging
Lewy Body Disease/*diagnostic imaging
Aged ; Aged, 80 and over ; Alzheimer Disease/pathology ; Alzheimer Disease/physiopathology ; Aphasia, Primary Progressive/pathology ; Aphasia, Primary Progressive/physiopathology ; Female ; Fluorodeoxyglucose F18 ; Frontotemporal Lobar Degeneration/diagnostic imaging ; Frontotemporal Lobar Degeneration/pathology ; Frontotemporal Lobar Degeneration/physiopathology ; Humans ; Language Tests ; Lewy Body Disease/pathology ; Lewy Body Disease/physiopathology ; Male ; Middle Aged ; Positron-Emission Tomography ; Radiopharmaceuticals
Czasopismo naukowe
Tytuł :
Suicide and Lewy body dementia: Report of a Lewy body dementia association working group.
Autorzy :
Armstrong MJ; Department of Neurology, University of Florida College of Medicine, Gainesville, Florida, USA.
Sullivan JL; Center for Healthcare Organization and Implementation Research, VA Boston Healthcare System, Boston, Massachusetts, USA.; Boston University School of Public Health, Boston, Massachusetts, USA.
Amodeo K; Department of Neurology, University of Rochester, Rochester, New York, USA.
Lunde A; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Tsuang DW; Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, USA.; VA Puget Sound Health Care System, Seattle, Washington, USA.
Reger MA; Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, USA.; VA Puget Sound Health Care System, Seattle, Washington, USA.
Conwell Y; Department of Psychiatry, University of Rochester Medical Center, Rochester, New York, USA.
Ritter A; Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, Nevada, USA.
Bang J; Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA.
Onyike CU; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, Maryland, USA.
Mari Z; Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, Nevada, USA.; Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA.
Corsentino P; Lewy Body Dementia Association, Lilburn, Georgia, USA.
Taylor A; Lewy Body Dementia Association, Lilburn, Georgia, USA.
Pokaż więcej
Źródło :
International journal of geriatric psychiatry [Int J Geriatr Psychiatry] 2021 Mar; Vol. 36 (3), pp. 373-382. Date of Electronic Publication: 2020 Nov 15.
Typ publikacji :
Journal Article
MeSH Terms :
Lewy Body Disease*
Suicide*
Humans
Czasopismo naukowe
Tytuł :
Proposed minimal essential co-expression and physical interaction networks involved in the development of cognition impairment in human mid and late life.
Autorzy :
Salehi Z; Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Arabfard M; Chemical Injuries Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Sadatpour O; Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Ohadi M; Iranian Research Center on Aging, University of Social Welfare and Rehabilitation Sciences, Kudakyar Alley, Daneshju Blvd., Evin, Tehran, Iran. .
Pokaż więcej
Źródło :
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2021 Mar; Vol. 42 (3), pp. 951-959. Date of Electronic Publication: 2020 Jul 16.
Typ publikacji :
Journal Article
MeSH Terms :
Alzheimer Disease*/genetics
Cognitive Dysfunction*/genetics
Diabetes Mellitus, Type 2*
Lewy Body Disease*
Cognition ; Gene Regulatory Networks ; Humans ; Pilot Projects
Czasopismo naukowe
Tytuł :
Nucleus Basalis of Meynert Stimulation for Lewy Body Dementia: A Phase I Randomized Clinical Trial.
Autorzy :
Maltête D; From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France. .
Wallon D; From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France.
Bourilhon J; From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France.
Lefaucheur R; From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France.
Danaila T; From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France.
Thobois S; From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France.
Defebvre L; From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France.
Dujardin K; From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France.
Houeto JL; From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France.
Godefroy O; From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France.
Krystkowiak P; From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France.
Martinaud O; From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France.
Gillibert A; From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France.
Chastan M; From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France.
Vera P; From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France.
Hannequin D; From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France.
Welter ML; From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France.
Derrey S; From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France.
Pokaż więcej
Źródło :
Neurology [Neurology] 2021 Feb 02; Vol. 96 (5), pp. e684-e697. Date of Electronic Publication: 2020 Nov 16.
Typ publikacji :
Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Basal Nucleus of Meynert*
Mental Recall*
Deep Brain Stimulation/*methods
Lewy Body Disease/*therapy
Aged ; Brain/diagnostic imaging ; Cross-Over Studies ; Double-Blind Method ; Fluorodeoxyglucose F18 ; Humans ; Implantable Neurostimulators ; Lewy Body Disease/physiopathology ; Lewy Body Disease/psychology ; Male ; Middle Aged ; Neuropsychological Tests ; Positron-Emission Tomography ; Postoperative Complications ; Prosthesis Implantation ; Radiopharmaceuticals ; Sleep ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Pharmacological management of dementia with Lewy bodies with a focus on zonisamide for treating parkinsonism.
Autorzy :
Panza F; Unit of Epidemiological Research on Aging 'Greatage Study', National Institute of Gastroenterology and Research Hospital IRCCS 'S. De Bellis' Castellana Grotte , Bari, Italy.
Lozupone M; Unit of Epidemiological Research on Aging 'Greatage Study', National Institute of Gastroenterology and Research Hospital IRCCS 'S. De Bellis' Castellana Grotte , Bari, Italy.; Neurodegenerative Disease Unit, Department of Basic Medicine, Neuroscience, and Sense Organs, University of Bari Aldo Moro , Bari, Italy.
Watling M; CNS & Pain Department, TranScrip Partners, Reading , UK.
Imbimbo BP; Department of Research and Development, Chiesi Farmaceutici, Parma , Italy.
Pokaż więcej
Źródło :
Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2021 Feb; Vol. 22 (3), pp. 325-337. Date of Electronic Publication: 2020 Oct 06.
Typ publikacji :
Journal Article
MeSH Terms :
Lewy Body Disease*/drug therapy
Brain ; Europe ; Humans ; Levodopa ; Zonisamide
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies